A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

NCT07114315 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
160
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso